Skip to main content
Figure 3 | BMC Pharmacology

Figure 3

From: Reserpine methonitrate, a novel quaternary analogue of reserpine augments urinary excretion of VMA and 5-HIAA without affecting HVA in rats

Figure 3

Diagram illustrating the effect of reserpine and reserpine methonitrate on the 24 h urinary excretion of HVA in rats. Each bar indicates the mean excretion of six animals. Significant difference from control group: *p < 0.05 Significant difference from reserpine treated group: # p < 0.05 NS-No significant difference between 5 and 10 mg/kg treated groups of reserpine methonitrate

Back to article page

BMC Pharmacology

ISSN: 1471-2210